A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer-Reference-Cited by-同舟云学术

A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer

Published:2015-11 Issue:16 Volume:51 Page:2345-2367
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Wolff Robert F.,Ryder Steve,Bossi Alberto,Briganti Alberto,Crook Juanita,Henry Ann,Karnes Jeffrey,Potters Louis,de Reijke Theo,Stone Nelson,Burckhardt Marion,Duffy Steven,Worthy Gillian,Kleijnen Jos

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference167 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. SEER stat fact sheets: prostate cancer [Internet];National Cancer Institute,2014

3. A review of the current epidemiology and treatment options for prostate cancer;Saman;Dis Mon,2014

4. Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA era;Glass;Urology,2013

5. Projections of the cost of cancer care in the United States: 2010–2020;Mariotto;J Natl Cancer Inst,2011

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypofractionated Dose Escalation Radiotherapy for High-risk Prostate Cancer: The Survival Analysis of the Prostate Cancer Study 5, a Groupe de Radio-oncologie Génito-urinaire du Quebec–led Phase 3 Trial;European Urology;2024-09

2. Development of deep learning-based novel auto-segmentation for the prostatic urethra on planning CT images for prostate cancer radiotherapy;Radiological Physics and Technology;2024-08-14

3. Artificial intelligence-based personalized clinical decision-making for patients with localized prostate cancer: surgery versus radiotherapy;The Oncologist;2024-07-31

4. Revolutionizing of bioactive natural products in prostate cancer research and care: Promising discoveries and future directions;Intelligent Pharmacy;2024-07

5. Hypofractionated radiation therapy combined with androgen deprivation therapy for high‐risk localized prostate cancer;Journal of Medical Imaging and Radiation Oncology;2024-03-13